With injectable semaglutide set to face generic entry in India in March, Novo Nordisk indicates plans to expand its oral ...

As the patent for semaglutide, the key ingredient in the popular weight-loss drug Ozempic, is set to expire in March, Indian ...

India’s pharma leaders urge a shift from generics to credible innovation at the Made In India book launch, highlighting challenges and opportunities for growth.

By Rishika Sadam and Sriparna Roy HYDERABAD, Feb 17 (Reuters) - Indian drugmaker Dr Reddy’s Laboratories hopes to launch a generic version of Novo Nordisk’s blockbuster weight‑loss drug Wegovy at a ...

Around 40% of generic drugs consumed in the US are imported from India. Nobody knows if, or by how much, these drugs could become dearer after April 2. Currently, the US imposes no tariffs on Indian ...

Until recently, Indians had few safe ways of joining the global craze for weight-loss drugs. Some smuggled them into the country when returning home from abroad; others chanced it with bootlegged ...

India’s pharmaceutical exports to the US will remain duty-free under a new interim trade deal, providing a major boost to pharma giants.

Dr Reddy’s plans to launch generic semaglutide in March 2026, potentially lowering prices in India’s fast-growing weight-loss ...

Prescription costs can add up month after month. That is why the government promotes generic medicine online through the Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana (PMBJP), making treatment more ...

Indian pharmaceutical giant Dr Reddy's Laboratories is set to introduce a generic version of Novo Nordisk's Wegovy in India, at a price potentially up to 60% lower than the branded product. With the ...

Kerala ranks second in India in Jan Aushadhi sales as more people shift from costly branded medicines to affordable generic ...